CAS Number 924012-43-1 ChemSpider 17253639 3D model (Jmol) Interactive image | PubChem CID 16095349 Formula C15H15N Molar mass 209.28 g/mol | |
 | ||
Legal status US: Investigational New Drug | ||
Centanafadine (INN) (former developmental code name EB-1020) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development by Neurovance in collaboration with Euthymics Bioscience as a treatment for attention deficit hyperactivity disorder (ADHD) that inhibits the reuptake of norepinephrine, dopamine and serotonin with a ratio of 1:6:14, respectively. As of August 2015, it is in phase II clinical trials.[1]
References
Centanafadine Wikipedia(Text) CC BY-SA